FindTrial
Sign In

Dose-response relationship of intravenous tranexamic acid with different doses to blood loss during primary total knee replacement

Dose-response relationship of intravenous tranexamic acid with different doses to blood loss during primary total knee replacement

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400083011
Enrollment
Unknown
Registered
2024-04-12
Start date
2024-04-15
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis

Interventions

underwent TKA/THA:none

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Primary Total knee or hip replacement over 18 years old

Exclusion criteria

Exclusion criteria: Have undergone knee or hip replacement Data incomplete

Design outcomes

Primary

MeasureTime frame
total blood loss;blood transfusion requirement;—

Countries

China

Contacts

Public ContactNie Yong

West China Hospital, Sichuan University

nieyong1983@wchscu.cn+86 28 8542 3971

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026